MEDPHLOW

LIVE

Serial Number

97642367

Owner

Phlow Corp.

Attorney

John R. Mills

Filing Date

Oct 21, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MEDPHLOW Trademark

Serial Number: 97642367

MEDPHLOW is a trademark filed by Phlow Corp. on October 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Class 40 - Treatment & Processing

Treatment of materials

Owner Contact Info

Phlow Corp. (12 trademarks)

424 Hull St., Suite 400
Richmond, VA 23224

Entity Type: 03

MEDPHLOW, LLC

424 Hull St., Suite 400
RICHMOND, VA 23224

Entity Type: 16

Legal Representation

Attorney of Record

John R. Mills

16 trademarks filed View all →

Correspondence Address

John R. Mills Mills IP Law, PLLC

1818 Library Street, Suite 500

Reston, VA 20190

United States

Trademark Details

Filing Date

October 21, 2022

Registration Date

Not Registered

Published for Opposition

June 20, 2023

Goods & Services

Custom manufacture of pharmaceuticals and medical devices for others

Medical devices for delivering measured amounts of pharmaceuticals to patients, sold empty; injection syringes; medical injection cartridges, sold empty and adapted for use with injection syringes for the delivery of pharmaceutical preparations; medical injection pumps, namely, infusion pumps; medical devices for use in treating patients, namely, infusion pump systems primarily consisting of infusion pumps for injection of pharmaceuticals for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of cardiovascular, respiratory, oncology, and critical care ailments, namely, drug cartridges or syringes for medical purposes, filled with pharmaceutical preparations, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders;medical devices for use in treating patients, namely, infusion pump systems containing pharmaceuticals for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders

Filing History

SOU TEAS EXTENSION RECEIVED

Feb 5, 2026 EEXT

ASSIGNED TO EXAMINER

Jan 23, 2026 DOCK

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 7, 2025 EXRA

SOU EXTENSION 4 GRANTED

Aug 6, 2025 EX4G

SOU EXTENSION 4 FILED

Aug 6, 2025 EXT4

SOU TEAS EXTENSION RECEIVED

Aug 6, 2025 EEXT

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

May 2, 2025 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 2, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 2, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 2, 2025 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 2, 2025 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 2, 2025 COAR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 15, 2025 EXRA

SOU EXTENSION 3 GRANTED

Jan 15, 2025 EX3G

SOU EXTENSION 3 FILED

Jan 15, 2025 EXT3

SOU TEAS EXTENSION RECEIVED

Jan 15, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 18, 2024 EXRA

SOU EXTENSION 2 GRANTED

Jul 18, 2024 EX2G

SOU EXTENSION 2 FILED

Jul 18, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Jul 18, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 9, 2024 EXRA

SOU EXTENSION 1 GRANTED

Feb 7, 2024 EX1G

SOU EXTENSION 1 FILED

Feb 7, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Feb 7, 2024 EEXT

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Oct 18, 2023 ASGN

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 15, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 20, 2023 NPUB

PUBLISHED FOR OPPOSITION

Jun 20, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 31, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 15, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

May 15, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 15, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

May 15, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

May 15, 2023 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 11, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 10, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 10, 2023 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Apr 4, 2023 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Apr 4, 2023 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 30, 2023 GNRN

NON-FINAL ACTION E-MAILED

Mar 30, 2023 GNRT

NON-FINAL ACTION WRITTEN

Mar 30, 2023 CNRT

ASSIGNED TO EXAMINER

Mar 28, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 6, 2022 NWOS

NEW APPLICATION ENTERED

Oct 25, 2022 NWAP

Related Trademarks

More from this Owner

CDMOX BY PHLOW

APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER

More in Same Class

ORIGIN SUPPLEMENTS

QUALIA LIFE SCIENCES

KLERAX

ELECTROLIFT

NEUTROGENA. POWER UP SKIN'S VITALS

GREENCARE PLUS